Your browser doesn't support javascript.
loading
Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.
Gurvich, C; Hudaib, A; Gavrilidis, E; Worsley, R; Thomas, N; Kulkarni, J.
Afiliação
  • Gurvich C; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia. Electronic address: caroline.gurvich@monash.edu.
  • Hudaib A; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia.
  • Gavrilidis E; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia.
  • Worsley R; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia.
  • Thomas N; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia.
  • Kulkarni J; Monash Alfred Psychiatry research centre, Monash University and The Alfred Hospital, Central Clinical School, Melbourne, Australia.
Psychoneuroendocrinology ; 100: 113-119, 2019 02.
Article em En | MEDLINE | ID: mdl-30299258
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Menopausa / Cognição / Cloridrato de Raloxifeno Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Menopausa / Cognição / Cloridrato de Raloxifeno Idioma: En Ano de publicação: 2019 Tipo de documento: Article